Literature DB >> 12438450

Disruption of tissue-type plasminogen activator gene in mice reduces renal interstitial fibrosis in obstructive nephropathy.

Junwei Yang1, Ryan W Shultz, Wendy M Mars, Rodney E Wegner, Yingjian Li, Chunsun Dai, Kari Nejak, Youhua Liu.   

Abstract

Tissue-type plasminogen activator (tPA) is one of the major components in the matrix proteolytic network whose role in the pathogenesis of renal interstitial fibrosis remains largely unknown. Here, we demonstrate that ablation of tPA attenuated renal interstitial fibrotic lesions in obstructive nephropathy. Mice lacking tPA developed less morphological injury and displayed a reduced deposition of interstitial collagen III and fibronectin as well as total tissue collagen in the kidneys after sustained ureteral obstruction, when compared with their wild-type counterparts. Deficiency of tPA selectively blocked tubular epithelial-to-myofibroblast transition (EMT), but did not affect myofibroblastic activation from interstitial fibroblasts. A marked decrease in matrix metalloproteinase-9 (MMP-9) induction was found in the obstructed kidneys of tPA(-/-) mice, which led to a dramatic preservation of the structural and functional integrity of tubular basement membrane (TBM). In vitro, tPA induced MMP-9 gene expression and protein secretion in renal interstitial fibroblasts. Thus, increased tPA is detrimental in renal interstitial fibrogenesis through a cascade of events that lead to MMP-9 induction, TBM destruction, and promotion of EMT. Our findings establish a crucial and definite importance of EMT in the pathogenesis of renal interstitial fibrosis at the whole-animal level.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12438450      PMCID: PMC151817          DOI: 10.1172/JCI16219

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  60 in total

Review 1.  Matrix metalloproteinases in renal development and disease.

Authors:  Oliver Lenz; Sharon J Elliot; William G Stetler-Stevenson
Journal:  J Am Soc Nephrol       Date:  2000-03       Impact factor: 10.121

Review 2.  Epithelial-mesenchymal transformation of renal tubular epithelial cells in vitro and in vivo.

Authors:  H Okada; T Inoue; H Suzuki; F Strutz; E G Neilson
Journal:  Nephrol Dial Transplant       Date:  2000       Impact factor: 5.992

Review 3.  Transdifferentiation comes of age.

Authors:  F Strutz; G A Müller
Journal:  Nephrol Dial Transplant       Date:  2000-11       Impact factor: 5.992

4.  Neuronal migration is retarded in mice lacking the tissue plasminogen activator gene.

Authors:  N W Seeds; M E Basham; S P Haffke
Journal:  Proc Natl Acad Sci U S A       Date:  1999-11-23       Impact factor: 11.205

5.  Hepatocyte growth factor activator (HGF-A) and its zymogen in human placenta.

Authors:  D A Somerset; A J Strain; S Afford; M J Whittle; M D Kilby
Journal:  Placenta       Date:  2000-09       Impact factor: 3.481

6.  Unilateral ureteral obstruction in neonatal rats leads to renal insufficiency in adulthood.

Authors:  R L Chevalier; B A Thornhill; A Y Chang
Journal:  Kidney Int       Date:  2000-11       Impact factor: 10.612

7.  Endogenous hepatocyte growth factor ameliorates chronic renal injury by activating matrix degradation pathways.

Authors:  Y Liu; K Rajur; E Tolbert; L D Dworkin
Journal:  Kidney Int       Date:  2000-11       Impact factor: 10.612

8.  Interstitial fibrosis in mice with overload proteinuria: deficiency of TIMP-1 is not protective.

Authors:  A A Eddy; H Kim; J López-Guisa; T Oda; P D Soloway
Journal:  Kidney Int       Date:  2000-08       Impact factor: 10.612

9.  Gelatinase B (MMP-9) is not essential in the normal kidney and does not influence progression of renal disease in a mouse model of Alport syndrome.

Authors:  K L Andrews; T Betsuyaku; S Rogers; J M Shipley; R M Senior; J H Miner
Journal:  Am J Pathol       Date:  2000-07       Impact factor: 4.307

10.  Activation of microglia reveals a non-proteolytic cytokine function for tissue plasminogen activator in the central nervous system.

Authors:  A D Rogove; C Siao; B Keyt; S Strickland; S E Tsirka
Journal:  J Cell Sci       Date:  1999-11       Impact factor: 5.285

View more
  89 in total

Review 1.  Role of extracellular matrix in kidney development and repair.

Authors:  Brigitte Lelongt; Pierre Ronco
Journal:  Pediatr Nephrol       Date:  2003-06-17       Impact factor: 3.714

2.  Advanced glycation end products induce tubular epithelial-myofibroblast transition through the RAGE-ERK1/2 MAP kinase signaling pathway.

Authors:  Jin H Li; Wansheng Wang; Xiao R Huang; Matthew Oldfield; Ann M Schmidt; Mark E Cooper; Hui Y Lan
Journal:  Am J Pathol       Date:  2004-04       Impact factor: 4.307

Review 3.  Cellular and molecular mechanisms of renal fibrosis.

Authors:  Youhua Liu
Journal:  Nat Rev Nephrol       Date:  2011-10-18       Impact factor: 28.314

4.  tPA activates LDL receptor-related protein 1-mediated mitogenic signaling involving the p90RSK and GSK3beta pathway.

Authors:  Ling Lin; Guojun Bu; Wendy M Mars; W Brian Reeves; Sakae Tanaka; Kebin Hu
Journal:  Am J Pathol       Date:  2010-08-19       Impact factor: 4.307

5.  Inhibition of integrin-linked kinase blocks podocyte epithelial-mesenchymal transition and ameliorates proteinuria.

Authors:  Young Sun Kang; Yingjian Li; Chunsun Dai; Lawrence P Kiss; Chuanyue Wu; Youhua Liu
Journal:  Kidney Int       Date:  2010-05-26       Impact factor: 10.612

6.  Focal adhesion kinase mediates TGF-beta1-induced renal tubular epithelial-to-mesenchymal transition in vitro.

Authors:  Bingqing Deng; Xiao Yang; Jianshe Liu; Fangfang He; Zhonghua Zhu; Chun Zhang
Journal:  Mol Cell Biochem       Date:  2010-02-23       Impact factor: 3.396

7.  Hepatocyte growth factor attenuates liver fibrosis induced by bile duct ligation.

Authors:  Jing-Lin Xia; Chunsun Dai; George K Michalopoulos; Youhua Liu
Journal:  Am J Pathol       Date:  2006-05       Impact factor: 4.307

Review 8.  The wound healing, chronic fibrosis, and cancer progression triad.

Authors:  Brad Rybinski; Janusz Franco-Barraza; Edna Cukierman
Journal:  Physiol Genomics       Date:  2014-02-11       Impact factor: 3.107

Review 9.  Obstructive nephropathy: insights from genetically engineered animals.

Authors:  Jean-Loup Bascands; Joost P Schanstra
Journal:  Kidney Int       Date:  2005-09       Impact factor: 10.612

Review 10.  New insights into epithelial-mesenchymal transition in kidney fibrosis.

Authors:  Youhua Liu
Journal:  J Am Soc Nephrol       Date:  2009-12-17       Impact factor: 10.121

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.